The human body cannot be understood only through biological and chemical processes but requires a higher understanding of the interplay between energy, matter, and information.

For decades, the field of medicine has been actively seeking treatments for human diseases by exploring connections among energy, matter, and information. This approach goes beyond a purely chemical or biological perspective and integrates the profound phenomena of quantum-physics into the realm of medical research. 

In this regard, we propose an interdisciplinary medical approach combining the sciences of chemistry, biology with physics to develop a new therapy that allows to control the cellular metabolism.

Our technology optimizes energy production to match the requirements of our cells by controlling mitochondrial function, among others. We secondarily induce the expression of genes to allow our cells to easily adapt to new conditions and environments. 

This epigenetic approach should make it possible to make great progress in the management of various pathologies but also to guarantee the adaptability of our species to changes in its ecological niche.

Our new technological approach (in development since more than 7 years) results into a first of its kind human in situ Quantum BioModulation therapy that allows for targeted modification, reproducibility of genes transcription factors, which can apply to all kind of diseases.

As our founder is a pediatric and adult heart surgeon and also has a specialization in biology (cellular respiration), the initial indications are addressing the heart, blood and the lung. Our animal trials show very promising results. In addition, we are working since the beginning in close collaboration with the physics department of EPFL in Lausanne.